Summary Statistics Only News Today

The artificial intelligence-driven EXPRESSO model uses genomic data, epigenetics and other information to identify risk genes for autoimmune disease.

Researchers at Penn State College of Medicine developed a new AI algorithm (EXPRESSO) which analyzes genetic data to predict autoimmune diseases earlier and identify potential therapies by pinpointing genes with cell-type specific effects.